chr4-174643892-G-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_006529.4(GLRA3):c.1289C>T(p.Thr430Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000867 in 1,614,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006529.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GLRA3 | ENST00000274093.8 | c.1289C>T | p.Thr430Ile | missense_variant | Exon 10 of 10 | 1 | NM_006529.4 | ENSP00000274093.3 | ||
| GLRA3 | ENST00000340217.5 | c.1244C>T | p.Thr415Ile | missense_variant | Exon 9 of 9 | 1 | ENSP00000345284.5 | |||
| ENSG00000301729 | ENST00000781118.1 | n.880+9088G>A | intron_variant | Intron 6 of 6 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152110Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000112 AC: 28AN: 251046 AF XY: 0.0000590 show subpopulations
GnomAD4 exome AF: 0.0000493 AC: 72AN: 1461840Hom.: 0 Cov.: 32 AF XY: 0.0000426 AC XY: 31AN XY: 727220 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000447 AC: 68AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.000484 AC XY: 36AN XY: 74442 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1289C>T (p.T430I) alteration is located in exon 10 (coding exon 10) of the GLRA3 gene. This alteration results from a C to T substitution at nucleotide position 1289, causing the threonine (T) at amino acid position 430 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at